Page results
-
Our team deliver care to people with MS and aim to provide specialist services, share information on how to manage symptoms, offer education sessions, medication options and rehabilitation services.
-
This information aims to support and supplement the information provided in the Be Active video available on uclh.nhs.uk/wellbeing
-
The Neurometabolic unit provides a unique range of investigations and clinical laboratory advice encompassing mitochondrial, neurotransmitter, pterin and amino acid disorders.
-
The clinical management of neuromuscular muscle wasting diseases such as motor neuron disease, myasthenia gravis, muscular dystrophy and peripheral neuropathy.
-
The Haemophagocytic Lymphohistiocytosis (HLH) Service was established at UCLH to offer high-quality care for people suspected of having HLH.
-
Skeletal muscle channelopathies are rare neuromuscular diseases that cause symptoms of episodic muscle weakness/paralysis or cause difficulty in relaxing muscles (the muscle can feel stuck or cramped) once they are contracted.
-
Medtronic are discontinuing the MiniMed™ Mio™ Infusion sets. If you are currently using MiniMed™ Mio™ infusion sets, you will need to change to an alternative infusion set before 31 March 2023. After this date, MiniMed™ Mio™ infusion sets will no longer be available.
-
Clinical Biochemistry HSL at 60 Whitfield Street has a fully automated laboratory offering a range of routine biochemical tests to UCLH and local GPs.
-
UCLH is the first NHS trust to pilot a personalised educational package for patients living with stroke.
-
This page explains what to do and what to avoid when your child has had extractions or minor oral surgery.
File results
-
FOI/2024/0776 - Buildings used by the Trust which still contain asbestos
-
FOI/2024/0814 - Asbestos Compensation 2021/22 - 2023/24
-
FOI/2024/0981 - Asbestos Containing Materials (ACMs)/ asbestos register/ asbestos management
-
UCLH board register of interests
-
UCLH Audit Committee terms of reference
-
-
-
-
-